Aducanumab CAS#: 1384260-65-4; 凯望编码 (ChemWhat Code): 1417416
Identification
| 英文名 | Aducanumab |
| CAS编号 | 1384260-65-4 |
Physical Data
No data available
Spectra
No data available
Route of Synthesis (ROS)
No data available
Safety and Hazards
No data available
Other Data
No data available
| Use Pattern |
| Aducanumab CAS#: 1384260-65-4 is a human monoclonal antibody and is the first and only Alzheimer’s disease treatment to address the clear pathology of the disease by reducing amyloid plaques in the brain. ADUHELM™ is indicated for the treatment of Alzheimer’s disease. This indication was granted under accelerated approval for amyloid plaque reduction in patients treated with ADUHELM™. |
试剂采购 | |
| 没有试剂厂商? | 向凯望发送快速询价 |
| 想要被列为试剂厂商? (付费服务) | 点击这里联系凯望 |
认证生产商 | |
| Watson Bio Ltd | https://www.watson-bio.com/ |
| 想要被列为认证生产商 (需要通过认证)? | 请下载并填写 这份表格并发邮件到approved-manufacturers@chemwhat.com |
其他供应商 | |
| Watson International Limited | 访问Watson官网 |
如需其他帮助，请联系我们 | |
| 联系我们获取其它信息或服务 | 点击这里联系凯望 |